BROADCASTS.com

b'Every week, The American Journal of Managed Care\\xae\\xa0recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.\\n\\nThis week, the top managed care stories included\\xa0CMS giving chimeric antigen receptor T-cell payments a boost; a US task force announcing that those at risk for pancreatic cancer should be screened; FDA revealing Novartis withheld data about a high-cost gene therapy.\\n\\nRead more about the stories in this podcast:\\nCMS Gives CAR T Payments Short-term Boost, Adjusts Hospital Wage Index: https://www.ajmc.com/focus-of-the-week/cms-gives-car-t-payments-shortterm-boost-adjusts-hospital-wage-index\\nStill No Call for Widespread Screening for Pancreatic Cancer, but USPSTF Says Yes for Those With Known Risk: https://www.ajmc.com/focus-of-the-week/still-no-call-for-widespread-screening-for-pancreatic-cancer-but-uspstf-says-yes-for-those-with-known-risk\\nWhat We\'re Reading: FDA Says Novartis Hid Data; Judge Halts Ark. Abortion Rules; New Phase in Opioid Suits: https://www.ajmc.com/newsroom/what-were-reading-fda-says-novartis-hid-data-judge-halts-ark-abortion-rules-new-phase-in-opioid-suits\\nOne Dose of HPV Vaccine Effective in Preventing Cervical Cancer Compared With Multiple Doses, Researchers Say: https://www.ajmc.com/newsroom/one-dose-of-hpv-vaccine-effective-in-preventing-cervical-cancer-compared-with-multiple-doses-researchers-say\\n"Not So Different": The Biosimilars Council Says Patent Abuses Are Costing Biosimilar Savings: https://www.centerforbiosimilars.com/podcast/not-so-different-the-biosimilars-council-says-patent-abuses-are-costing-biosimilar-savings'